Slide Insurance CRO sells 11,374 shares at $24.62
Slide’s chief risk officer exercised and sold 11,374 shares under a pre-set Rule 10b5-1 trading plan, leaving a significant stock option position outstanding.
Rhea-AI Filing Summary
Slide Insurance Holdings, Inc. (SLDE) reported that Chief Risk Officer Matthew Paul Larson executed an option exercise-and-sale transaction on September 3, 2026. He exercised options for 11,374 shares of common stock at $1.38 per share and sold the same 11,374 shares at a weighted average price of $24.62 per share, with sale prices ranging from $24.50 to $24.87, in a transaction reported as occurring in the open market or a private transaction. The exercise and sale were carried out under a Rule 10b5-1 trading plan adopted on May 4, 2026. After the transaction, Larson held 38,874 stock options; a related disclosure states that, of 50,248 stock options reported, 36,498 are vested and exercisable and the remaining 13,750 are scheduled to vest on July 14, 2027, with the options expiring on February 24, 2032.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F1, F3 | 11,374 | $0.00 | $0.00 |
| Exercise | Common Stock | 11,374 | $1.38 | $16K |
| Sale | Common Stock F1, F2 | 11,374 | $24.62 | $280K |
Footnotes (3)
- F1. Exercised and sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 4, 2026.
- F2. Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $24.50 to $24.87 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- F3. Of the 50,248 stock options reported herein, 36,498 are vested and exercisable. The remaining 13,750 vest on July 14, 2027.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
vested and exercisable financial
FAQ
What insider transaction did SLDE’s chief risk officer report on September 3, 2026?
Was the SLDE insider transaction made under a Rule 10b5-1 trading plan?
What stock options does the SLDE chief risk officer retain after this Form 4 transaction?
What is the exercise price and expiration date of the SLDE options involved?
What role does Matthew Paul Larson hold at SLDE in this Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.